jakavi 5 mg comprimidos
novartis de venezuela, s.a. - ruxolitinib - comprimidos - 5 mg
jakavi comprimidos 20 mg (ruxolinitib fosfato)
novartis chile s.a. - ruxolitinib - sin formulas
jakavi 5 mg comprimidos
novartis pharma a.g. [ch] switzerland - ruxolitinib----5.00 mg - comprimidos - cada comprimido contiene: fosfato de ruxolitinib cas 941678-49-5----6.60 mg equivalente a ruxolitinib----5.00 mg
jakavi 15 mg comprimidos
novartis pharma a.g. [ch] switzerland - ruxolitinib----15.000 mg - comprimidos - cada comprimido contiene: fosfato de ruxolitinib cas 941678-49-5----19.80 mg equivalente a ruxolitinib----15.00 mg
jakavi 20mg comprimidos
novartis pharma a.g. [ch] switzerland - ruxolitinib----20.00 mg - comprimidos - cada comprimido contiene: fosfato de ruxolitinib cas 941678-49-5----26.40 mg equivalente a ruxolitinib----20.00 mg
inrebic
bristol myers squibb pharma eeig - fedratinib dihydrochloride monohydrate - myeloproliferative disorders; primary myelofibrosis - agentes antineoplásicos - inrebic is indicated for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis, post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis who are janus associated kinase (jak) inhibitor naïve or have been treated with ruxolitinib.
jakavi 5 mg comprimido
scienza uruguay - comprimido - ruxolitinib 5 mg comprimido
jakavi 10 mg comprimido
scienza uruguay - comprimido - ruxolitinib 10 mg comprimido
jakavi 15 mg comprimido
scienza uruguay - comprimido - ruxolitinib 15 mg comprimido
jakavi 20 mg comprimido
scienza uruguay - comprimido - ruxolitinib 20 mg comprimido